Steinbach S C, Triani R, Bennedsen L, Gabel A, Haeusler O, Wohlrab J, Neubert R H H
Pharmazie. 2017 Aug 1;72(8):440-446. doi: 10.1691/ph.2017/7004.
Ceramide [NP] is an integral component of the stratum corneum (SC) lipid matrix and is capable of forming tough and stable lamellar structures. It was proven, that in skin diseases as psoriasis or atopic dermatitis different ceramide (CER) classes, including [NP], are degraded. It is obvious that topically application of CER on impaired skin is useful for repairing the skin barrier but a tendency for low penetration due to its poor solubility in conventional dosage forms was observed. Therefore, a stable and physiologic compatible colloidal carrier system, a microemulsion (ME), was developed and characterized. The increasing knowledge of the new colloidal systems in this last decade shows their benefits in dermal application. Isosorbide (Polysorb P) was incorporated into the ME developed. It was expected that Polysorb P has a retarder potential in order to accumulate the CER in the SC, the outermost layer of the skin. Thereby the CER [NP] would be able to interact with the affected skin layers to strengthen the skin barrier. The release and penetration behavior of the CER [NP] from the ME was assessed ex vivo in a Franz diffusion cell. The results of the study showed that CER [NP] penetrate largely in the upper layers of the skin (from SC to stratum basale), which was the desired region. A recovery in the acceptor could not be detected that underlines an accumulation in upper layers. Furthermore, significantly increased values for the SC for the ME with retarder were not received. No differences in the concentrations of CER [NP] were observed. However, the toxicity of MEs was investigated using heńs egg test chorioallantoic membrane (HET-CAM). For the isosorbide-containing ME no difference was obtained in comparison to the non-containing. The results showed that both MEs are safe to be used on the skin for the controlled penetration of CER [NP] into the skin. The isosorbide had no effect on the irritating effect as well as on the penetration of the used CER.
神经酰胺[NP]是角质层(SC)脂质基质的重要组成部分,能够形成坚韧且稳定的层状结构。已证实,在银屑病或特应性皮炎等皮肤病中,包括[NP]在内的不同神经酰胺(CER)类别会被降解。显然,在受损皮肤上局部应用CER有助于修复皮肤屏障,但由于其在传统剂型中的溶解度较差,存在渗透力低的倾向。因此,开发并表征了一种稳定且生理相容性良好的胶体载体系统——微乳(ME)。过去十年中对新型胶体系统的了解不断增加,显示出它们在皮肤应用中的优势。将异山梨醇(聚山梨醇酯P)加入所开发的ME中。预计聚山梨醇酯P具有缓释潜力,以便在皮肤最外层的角质层中积累CER。从而使CER[NP]能够与受影响的皮肤层相互作用,增强皮肤屏障。在Franz扩散池中对CER[NP]从ME中的释放和渗透行为进行了体外评估。研究结果表明,CER[NP]主要渗透到皮肤的上层(从角质层到基底层),这是理想的区域。在接受器中未检测到回收,这表明在上层有积累。此外,含阻滞剂的ME在角质层中的值没有显著增加。未观察到CER[NP]浓度的差异。然而,使用鸡胚绒毛尿囊膜(HET-CAM)研究了ME的毒性。含异山梨醇的ME与不含异山梨醇的ME相比没有差异。结果表明,两种ME在用于皮肤使CER[NP]可控渗透到皮肤方面都是安全的。异山梨醇对所用CER的刺激作用以及渗透均无影响。